Christopher G Nasveschuk

ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Venues

Communications chemistry

ACS chemical biology

Journal of medicinal chemistry

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Qi Hao, Manoj K Rathinaswamy, Kelly L Klinge, Matthew Bratkowski, Amirhossein Mafi, Christina K Baumgartner, Keith M Hamel, Gesine K Veits, Rinku Jain, Claudio Catalano, Mark Fitzgerald, Alexander W Hird, Eunice Park, Harit U Vora, James A Henderson, Kenton Longenecker, Charles W Hutchins, Wei Qiu, Giovanna Scapin, Qi Sun, Vincent S Stoll, Chaohong Sun, Ping Li, Dan Eaton, David Stokoe, Stewart L Fisher, Christopher G Nasveschuk, Marcia Paddock, Michael E Kort
Mechanistic insights into a heterobifunctional degrader-induced PTPN2/N1 complex. Communications chemistry 7 (1) (2024)
Qi Hao, Manoj K Rathinaswamy, Kelly L Klinge, Matthew Bratkowski, Amirhossein Mafi, Christina K Baumgartner, Keith M Hamel, Gesine K Veits, Rinku Jain, Claudio Catalano, Mark Fitzgerald, Alexander W Hird, Eunice Park, Harit U Vora, James A Henderson, Kenton Longenecker, Charles W Hutchins, Wei Qiu, Giovanna Scapin, Qi Sun, Vincent S Stoll, Chaohong Sun, Ping Li, Dan Eaton, David Stokoe, Stewart L Fisher, Christopher G Nasveschuk, Marcia Paddock, Michael E Kort
Mechanistic insights into a heterobifunctional degrader-induced PTPN2/N1 complex. Communications chemistry 7 (1) (2024)
Alexander M Taylor, Chris Bailey, Lisa D Belmont, Robert Campbell, Nico Cantone, Alexandre Côté, Terry D Crawford, Richard Cummings, Kevin DeMent, Martin Duplessis, Megan Flynn, Andrew C Good, Hon-Ren Huang, Shivangi Joshi, Yves Leblanc, Jeremy M Murray, Christopher G Nasveschuk, Adrianne Neiss, Florence Poy, F Anthony Romero, Peter Sandy, Yong Tang, Vickie Tsui, Laura Zawadzke, Robert J Sims, James E Audia, Steven F Bellon, Steven R Magnuson, Brian K Albrecht, Andrea G Cochran
GNE-064: A Potent, Selective, and Orally Bioavailable Chemical Probe for the Bromodomains of SMARCA2 and SMARCA4 and the Fifth Bromodomain of PBRM1. Journal of medicinal chemistry 65 (16) (2022)
Jennifer R Diamond, Todd M Pitts, Dana Ungermannova, Christopher G Nasveschuk, Gan Zhang, Andrew J Phillips, Stacey M Bagby, Jessica Pafford, Betelehem W Yacob, Timothy P Newton, John J Tentler, Brian Gittleman, Sarah J Hartman, John A DeMattei, James D Winkler, Michael K Wendt, William P Schiemann, S Gail Eckhardt, Xuedong Liu, Anthony D Piscopio
Preclinical Development of the Class-I-Selective Histone Deacetylase Inhibitor OKI-179 for the Treatment of Solid Tumors. Molecular cancer therapeutics 21 (3) (2022)
Scott J Eron, Hongwei Huang, Roman V Agafonov, Mark E Fitzgerald, Joe Patel, Ryan E Michael, Tobie D Lee, Ashley A Hart, Jodi Shaulsky, Christopher G Nasveschuk, Andrew J Phillips, Stewart L Fisher, Andrew Good
Structural Characterization of Degrader-Induced Ternary Complexes Using Hydrogen-Deuterium Exchange Mass Spectrometry and Computational Modeling: Implications for Structure-Based Design. ACS chemical biology 16 (11) (2021)

Christopher G Nasveschuk.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Christopher G Nasveschuk